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Acanthocytic RBCs are a peculiar diag-
nostic feature of chorea-acanthocytosis
(ChAc), a rare autosomal recessive neuro-
degenerative disorder. Although recent
years have witnessed some progress in
the molecular characterization of ChAc,
the mechanism(s) responsible for genera-
tion of acanthocytes in ChAc is largely
unknown. As the membrane protein
composition of ChAc RBCs is similar to
that of normal RBCs, we evaluated the
tyrosine (Tyr)–phosphorylation profile
of RBCs using comparative proteomics.
Increased Tyr phosphorylation state of
several membrane proteins, including
band 3, -spectrin, and adducin, was
noted in ChAc RBCs. In particular, band
3 was highly phosphorylated on the
Tyr-904 residue, a functional target of
Lyn, but not on Tyr-8, a functional target
of Syk. In ChAc RBCs, band 3 Tyr phos-
phorylation by Lyn was independent of
the canonical Syk-mediated pathway.
The ChAc-associated alterations in RBC
membrane protein organization appear
to be the result of increased Tyr phos-
phorylation leading to altered linkage of
band 3 to the junctional complexes in-
volved in anchoring the membrane to
the cytoskeleton as supported by coim-
munoprecipitation of -adducin with
band 3 only in ChAc RBC-membrane
treated with the Lyn-inhibitor PP2. We
propose this altered association be-
tween membrane skeleton and mem-
brane proteins as novel mechanism in
the generation of acanthocytes in ChAc.
(Blood. 2011;118(20):5652-5663)
Introduction
Chorea-acanthocytosis (ChAc) is a rare autosomal recessive neuro-
degenerative disorder of the neuroacanthocytosis group.1-3 ChAc is
characterized by a neurodegeneration of the basal ganglia, which is
associated with the presence of acanthocytes, abnormal erythro-
cytes with thorn-like protrusions, in the peripheral circulation.1-3
Molecular studies have identified mutation(s) of the VPS13A gene
(chromosome 9), encoding a 360-kDa protein chorein of unknown
function that is ubiquitously expressed in the brain.2,4-6 To date, 92
mutations on the VPS13A gene have been reported, resulting in low
or absent synthesis of chorein or in expression of a functionally
defective protein at normal levels.2,4-6 Chorein has been detected in
mature RBCs but it is partially or completely absent in RBCs from
patients with ChAc.6 Because of the lack of knowledge on the
structure of chorein and on its interaction with other proteins, we
can only speculate on the role of chorein in RBC homeostasis.
In the RBC membrane, 2 major multiprotein complexes bridge
the lipid bilayer with the integral membrane proteins to the
spectrin-actin cytoskeleton: the ankyrin complex and the junctional
or 4.1R complex.7 Electron microscopy of ChAc RBCs reveals
ultrastructural abnormalities in the membrane skeleton as indicated
by a heterogeneous distribution of the cytoskeleton. Condensed
skeletal structures around protrusions and a less filamentous
structure in some large membrane patches indicate a perturbation
of membrane cytoskeleton network associated with the membrane
protrusions that characterize acanthocytes.8 These structural data
were also supported by the observation that ChAc patients have a
fraction of dense RBCs containing acanthocytes with a reduced cell
K content compared with normal controls.9 RBCs from ChAc
patients did not show overall abnormalities in RBC membrane
protein composition and content, although there is accumulating
evidence for neuroacanthocytosis-specific abnormalities in band 3
structure and function.10 Increased membrane serine-threonine
phosphorylation levels, mainly of band 3 and spectrin, increased
levels of band 3 tyrosine (Tyr) phosphorylation, and increased
activity of membrane-associated casein-kinase has also been
described in ChAc RBCs.11 Increased amounts of N (-glutamyl)
lysine isopeptides associated with the RBC membrane have also
been reported in a few ChAc patients, indicating a possible
perturbation of the anchoring bridges between the membrane and
the cytoskeleton.12,13 There are no consistent data indicating a
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relation between lipid content and/or composition and acanthocyto-
sis in ChAc patients.
The recent development of proteomic techniques has yielded a
description of RBC membrane proteome, mainly in normal
RBCs.14-18 We used comparative proteomics to study membrane
proteome of RBCs from patients with ChAc in relation to normal
controls. Differences between normal and ChAc RBCs included
changes in Tyr phosphorylation state of band 3, -spectrin, and
other members of the anchoring complexes in ChAc RBCs. We
also found abnormal activation of Lyn, a Tyr-kinase of the Src
family, independent from its canonical signaling pathway involv-
ing primary phosphorylation of Syk. These finding suggest that
altered phosphorylation of band 3 and membrane skeletal
proteins may play a role in the development of acanthocyte
morphology in ChAc.
Methods
Study design
We studied 9 patients with ChAc based on clinical neurologic manifesta-
tions, presence of acanthocytes (Figure 1A), and confirmation by either
immunoblot analysis for chorein and/or molecular analysis for VPS13A
mutations as previously described.6 The demographic and molecular data of
patients are reported in Table 1. Blood was obtained by venipuncture using
EDTA as an anticoagulant, according to the guidelines approved by the
local Ethics Committees for human subject studies of all participating
institutions involved. Blood samples (ChAc patients and healthy control
donors) were shipped to Verona and Nijmegen at 4°C and processed
immediately after arrival. Erythrocytes were isolated from whole blood
after removal of white blood cells and platelets as previously de-
scribed.19 Because ChAc patients have a dense fraction of RBCs
Figure 1. Proteomic analysis of RBC membrane fractions shows differences in ChAc compared with healthy controls. (A) Morphology of RBCs from control and ChAc
subjects. (B-E) RBCs from control (C) and ChAc were fractionated in fraction 1 (F1) corresponding to a density  1.074, containing reticulocytes, and fraction 2 (F2)
corresponding to a density  1.092, containing acanthocytes. (B) The fractionated RBC membrane proteins were separated by 1DE and stained with colloidal Coomassie
blue. The bands that were identified by mass spectrometry are indicated: -spectrin (accession no. P11277), 48% coverage; -spectrin (accession no. P02549), 52%
coverage; band 3 (accession no. P027330), 25% coverage; band 4.1R (accession no. P11171), 22% coverage; band 4.2 (accession no. P16452), 18% coverage; -actin
(accession no. P60709), 26% coverage; GAPDH (accession no. P04406), 18% coverage; and Prx-2 (accession no. P32119), 32% coverage. The figure shows a representative
of 9 experiments performed with similar results. (C) Western blot (Wb) analysis of RBC membranes separated by 1DE with specific antibodies against Prx-2, GAPDH, flotillin-1,
and stomatin proteins of fractionated RBCs from controls (C) and ChAc subjects. Actin was used as loading control. The data are representative for 8 experiments. (D-E) The
membrane proteins of fractionated RBCs (see “Study design”) were separated by 2DE. Twin 2DE gels were run: one stained with colloidal Coomassie and the other transferred
to membrane for Western blot analysis. (D) The colloidal Coomassie blue–stained gels underwent image analysis, and differently expressed proteins were identified by mass
spectrometry (see “Comparative proteomic analysis”; supplemental Methods). Red and green spots indicated the differently expressed proteins based on image analysis. The
identified proteins are reported in supplemental Table 2. The figures show 1 representative experiment from a total 8 experiments performed. (E) Western blot (Wb) analysis of
the 2DE maps with specific anti–protein p55 antibody on F1 RBCs from control and ChAc subjects (validating the differently expressed spots 32C, 33C, and 34C in panel 1D
and supplemental Table 2), anti–flotillin-1 antibody on F1 RBCs from control and ChAc subjects (validating the differently expressed spots 40C in panel D and supplemental
Table 2), and anti–protein 4.1R antibody on F2 RBCs from control and ChAc subjects (validating the differently expressed spots 64C-68C in panel D and supplemental Table 2).
The figures show one representative experiment of 3 experiments performed with similar results.
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enriched in acanthocytes,9 we analyzed RBCs separately according to
RBC density.
For semiquantitative proteome analyses, we separated the RBCs in 1 of
2 ways. Cells were separated into 5 fractions (I-V) based on volume and
density using counter flow centrifugation followed by Percoll gradient
centrifugation, with fraction I containing the youngest and fraction V the
oldest erythrocytes and acanthocytes. The membrane proteomes of these
fractions were analyzed as described previously.15
Alternatively, RBCs were separated into 2 fractions: fraction 1 (F1)
corresponding to a density 1.074, containing reticulocytes, and fraction 2
(F2) corresponding to a density  1.092, containing acanthocytes, for
proteomic analysis by 2-dimensional electrophoresis matrix-assisted laser
desorption/ionization time-of-flight mass spectrometry, which requires a
relatively large amount of proteins for the analysis.19,20 Where indicated,
control RBCs were incubated in the presence of sodium orthovanadate as
previously described by Bordin et al.21
RBC morphology, membrane preparation, and membrane
cytoskeleton extraction
To study cell morphology, RBCs were fixed as previously described by
Matte et al22 and imaged using a Leica TCS SP5 II microscope equipped
with an objective HCX PL APO  blue 63.0, NA 1.40 oil.
RBC membrane fractions were obtained by lysing 1 volume of packed
cells in 10 volumes of ice-cold phosphate lysis buffer (5mM Na2HPO4, pH
8.0, in the presence of protease inhibitors, cocktail tablet, Roche Diagnos-
tics; 3mM benzamidine, 1mM Na3VO4). Samples were incubated for 10
minutes on ice and centrifuged for 10 minutes at 12 000g at 4°C.
Membranes were then washed 4 times by centrifugation at 12 000g at 4°C
with phosphate lysis buffer until they appeared almost white.15
To assess the strength of the interaction between cytoskeleton and the
lipid bilayer, cytoskeletal proteins were extracted by resuspending mem-
branes (100 	g of total protein) in 1 mL of 100mM Na2CO3, pH 11. The
suspension was passed 5 times through a 25-gauge needle, mixed and
incubated for 30 minutes at 4°C. Soluble proteins were removed by
centrifugation for 30 minutes at 200 000g. This procedure was repeated
twice. Proteins from pelleted membranes were extracted by either detergent
or NaCl. Briefly, packed erythrocyte membranes were incubated for 1 hour
at 4°C with 50mM Tris-HCl, pH 7.5, 10% glycerol, 1mM sodium
orthovanadate, and protease inhibitor cocktail in the absence or the
presence of either 1% Triton X-10022 or 0.6M NaCl. After ultracentrifuga-
tion, the supernatants and precipitates were analyzed by 1-dimensional
electrophoresis (1DE) and either stained with colloidal Coomassie or
transferred to membranes for immunoblot analysis with the appropriate
antibody.22
Comparative proteomic analysis
Semiquantitative proteomic analysis. All the analyses were performed
essentially as previously described.15 Details are reported in supplemental
Methods (available on the Blood Web site; see the Supplemental Materials
link at the top of the online article). Samples of various origins were
quantified by the label-free peptide counting method emPAI, which
calculates protein abundance, as has been applied for a quantitative analysis
of RBC membranes during storage.15 Data were normalized using the
median emPAI value per sample. This protocol has been shown to result in a
reliable identification of all erythrocyte membrane proteins and to enable
semiquantification of the major protein species.15 To be able to apply this
method to multiple samples in an efficient and cost-effective manner, we
reduced the running time of the SDS-PAGE step and extended the running
time of the HPLC gradient from 1.5 to 4 hours. This “one-slice” method
yielded 300 to 400 reliably identified proteins, comparable with those found
earlier by us and others using one-dimensional as well as 2-dimensional
electrophoresis.15,23,24
Gel electrophoresis of RBC membrane. For 1DE, RBC membranes
were solubilized in sample buffer (50mM Tris, pH 6.8, 100mM -mercap-
toethanol, 2% volume/volume SDS, 10% volume/volume glycerol, a few
grains of bromophenol blue), and loaded on to either 8% or 10%
polyacrylamide gels. Whenever peroxiredoxin-2 (Prx-2) was evaluated,
RBCs were lysed in the presence of NEM (100mM) in the phosphate lysis
buffer and solubilized in sample buffer with NEM (100mM).19,20,22 For
2-dimensional electrophoresis (2DE), RBC membranes were delipidated
and separated by 2DE as previously described.19,20,22 Details are presented
in supplemental Methods. After electrophoresis, the gels were stained with
colloidal Coomassie followed by image analysis using “Progenesis Same-
Spots” software (Non Linear Dynamics).20 Details of image analysis are
reported in supplemental Methods. The selected bands or spots were
identified by 2DE matrix-assisted laser desorption/ionization time-of-flight
mass spectrometry/mass spectrometry analysis (see supplemental Methods
for more details).
Immunoblot analysis and dephosphorylation of blotted
proteins
Proteins were transferred from 1D or 2D gels to membranes for immuno-
blot analysis and probed with specific antibodies as previously de-
scribed19,20 (see also supplemental Methods for details). Dephosphorylation
of blotted proteins was carried out as described in supplemental Methods.
Peptides and recombinant proteins
The phosphopeptide of band 3 (amino acids 1-26) and its unphosphorylated
analog were synthesized as described previously.25 The recombinant
GST-Lyn/SH3 domain was expressed and purified according to the protocol
described by Trentin et al.26 The GST-Lyn/SH2 domain was expressed and
purified as previously reported.27
Phosphorylation of erythrocyte membranes
Erythrocyte membranes (3 	g protein) were phosphorylated for 10 minutes
at 30°C in 30 	L of an incubation mixture containing 50mM Tris-HCl, pH
Table 1. Demographic and molecular data of control and ChAc subjects
Sex Age, y Molecular defect/WB analysis for chorein
Controls (n  12) 9 females/3 males 35.6 
 2.3
ChAc 1 Female 35 Intron 3: c.188–5T  G (splice site); mutation on other allele unknown/ND
ChAc 2 Female 34 ND/chorein absent
ChAc 3 Female 30 Exon 37: c.4286G  C;p.A1428P; intron 55: c.7806G  A;p.P2602P
(splice site)/chorein absent
ChAc 4 Female 40 Exon 34: c.3889C  T; p.R1297X; exon 36: c.4216del; p.V1406CfsX20/ND
ChAc 5 Male 47 Intron 22: c.2288  2T  C; (splice site mutation); intron 61: c.8472–1G  C;
(splice site mutation)/ND
ChAc 6 Female 56 (homozygous) Exon 13: c.1115del; p.K372SfsX2/ND
ChAc 7 Male 32 ND/chorein absent
ChAc 8 Female 38 Intron 6: c.495  5G  A (splice site mutation); exon 40: c.4903_4906del;
p.K1635VfsX6/ND
ChAc 9 Female 40 ND/chorein absent
WB indicates Western blot; and ND, not determined.
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7.5, 10mM MnCl2, 30	M ATP, 200	M sodium orthovanadate, and 15nM
of exogenous Lyn Tyr kinase, purified from rat spleen.27 When required, the
phosphorylation assays were carried out in the absence or presence of the
GST-Lyn/SH2 domain or the GST-Lyn/SH3 domain, respectively. The
solubilized membranes were analyzed by immunoblot with the anti–p-Tyr
antibody. The membranes were reprobed with anti–-actin antibody as a
loading control. When indicated, washed RBCs from control and ChAc
subjects were incubated with and without the Src family kinase inhibitors
PP1 (10	M) and PP2 (10	M) as previously reported.19,27
Preparation of Syk-phosphorylated membranes of erythrocytes
Membranes were phosphorylated by 15nM p36Syk for 10 minutes in 50mM
Tris-HCl, 10mM MnCl2, 30	M ATP, and 200	M sodium orthovanadate.
Syk-phosphorylated membranes were separated from p36Syk, ATP, and
other reagents by centrifugation and washed twice as previously reported.27
Identification of putative phosphorylation targets of Lyn by
sequence and structure analyses
The sequences of the different Tyr-phosphorylated proteins were obtained
from the NCBI reference sequence database using their accession numbers.
They were analyzed by means of the GPS Version 2.0 software to identify
putative Lyn target sites.28 Details are reported in supplemental Methods.
Results
Proteomic analysis of ChAc RBC membranes shows
differences compared with membranes from healthy controls
Analysis of ChAc RBC membrane proteins by 1DE followed by
protein staining showed that the membrane protein composition of
ChAc RBCs was very similar to that of RBCs from healthy
controls, except for a band at approximately 20 kDa, which was
markedly reduced in the high-density (F2) fraction of RBCs of
ChAc patients (Figure 1B). This band was excised from the gel and
identified by mass spectrometry as Prx-2. Analysis of the RBC
membrane protein composition by comparative semiquantitative
proteomic approach showed an enrichment in ChAc RBC mem-
branes for spectrin, ankyrin, and protein 4.2 major component of
the ankyrin complex (supplemental Table 1). The concentrations of
the raft-associated flotillins did not differ between control and
ChAc samples. However, stomatin, another raft-associated protein,
was conspicuously enriched in the ChAc samples (supplemental
Table 1). The membrane association of GAPDH was variable with
an increase in 2 of 3 ChAc patients and a decrease in one ChAc
patient (supplemental Table 1). In addition, proteins of the small G
protein family were hardly detectable in the control samples but
were abundant in the patients’ membrane fractions. All membrane
samples contained similar amounts of heat shock proteins (data not
shown). Immunoblot analysis with specific antibodies confirmed:
(1) a reduction of membrane-associated Prx-2 in both low- and
high-density fractions of ChAc RBCs compared with controls;
(2) an increased membrane association of GAPDH in the high-
density fraction of ChAc RBCs that were enriched in acanthocytes
compared with normal controls; and (3) a similar membrane
content of flotillin 1 in ChAc and control RBCs (Figure 1C).
For a more detailed analysis, we performed 2DE followed by
identification of the differently expressed proteins by mass spectrom-
etry. Using a 2-fold abundance as the selection criterion (see
“Comparative proteomic analysis”), we detected 50 spots that were
differently expressed in high-density fraction (F2) of ChAc RBCs
and 41 spots differently expressed in low-density fraction (F1) of
ChAc RBCs (Figure 1D; supplemental Table 2). It is to be noted
that our protein identifications are in strong accordance with
previously published 2DE maps of RBC membrane.14,20 The
identified proteins were divided into 8 functional clusters: I,
proteins of the anchoring complexes; II, cytoskeleton proteins; III,
raft-related proteins; IV, membrane channels and transporters; V,
intracellular signaling proteins; VI, metabolic enzymes; VII, pro-
teins of the ubiquitin-proteasome system; and VIII, stress response
proteins and chaperones.20 We validated the 2DE data by immuno-
blot analysis of some of the identified proteins: protein p55 in F1
fractionated RBCs, flotillin-1 in F1 fractionated RBCs, and protein
4.1 in F2 fractionated RBCs (Figure 1E). The differences in
membrane and cytoskeleton proteins in ChAc RBC observed in
2DE maps were mainly related to protein 2DE mobility shift,
possibly reflecting protein post-translational modifications, such as
phosphorylation (Figure 1D-E; supplemental Table 2). This is also
supported by the similar abundance of membrane and cytoskeleton
proteins in 1DE analysis of ChAc and control RBC membranes
(Figure 1B).
Differential extraction of membrane proteins reveals
differences in membrane organization in ChAc RBCs
To explore putative ChAc-associated changes in membrane organi-
zation, we assessed the strength of binding of the major erythrocyte
membrane and cytoskeletal proteins to the lipid bilayer by analyz-
ing the proteome after incubation of the membrane fractions with
100mM Na2CO3, pH 11 (see “RBC morphology, membrane
preparation, and membrane cytoskeleton extraction”). In controls,
this alkaline treatment led to the virtual disappearance of most
cytoskeletal and membrane-associated proteins, such as spectrin,
ankyrin, and GAPDH. This was accompanied by enrichment of
most integral membrane proteins, including band 3 and Glut1, and
by a large increase in the concentration of stomatin (supplemental
Table 3). The loss of GPC, but not GPA, suggests that a
considerable fraction of the GPC molecules is extracted together
with the cytoskeleton. As in control samples, extraction of ChAc
membranes resulted in the depletion of the same proteins as seen in
normal membranes and also in enrichment for most integral
membrane proteins with band 3 as a notable exception (supplemen-
tal Table 3).
Because recent studies have suggested that changes in mem-
brane protein phosphorylation state play an important role in the
modulation of RBC membrane protein-protein functional cross-
talk and stability of multiprotein structures,29,30 we studied the Tyr
phosphorylation profile of RBC membrane from control and ChAc
subjects.
The Tyr-phosphorylation state of ChAc RBC membrane
proteins is increased compared with normal controls
Evaluation of the Tyr phosphorylation pattern of RBC membranes
from normal and ChAc density-separated RBCs by immunoblot
analysis showed a higher Tyr phosphorylation state of various
membrane proteins in ChAc RBCs (Figure 2).
The 2DE Tyr-phospho maps confirmed the presence of trains of
Tyr-phosphorylated proteins in the gel area corresponding to the
differently expressed spots noted in 2DE maps: ankyrin (17-18C in
F1 and 54C-57C and 60C-62C in F2 from ChAc RBCs), protein
4.1R (21C, 23C, 25 C in F1 and 64C-68C in F2 from ChAc RBCs),
protein p55 (32C-34C in F1 from ChC RBCs) and dematin
(88C-89C in F2 from ChAc RBCs; Figure 1D; supplemental Table
2). These data are also supported by the absence of reactivity when
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the membranes were treated with -phosphatase, which was used
to remove phosphate groups from blotted proteins (Figure 2A
bottom panel). The differently Tyr-phosphorylated proteins were
excised from the 1D-stained gels and identified by mass spectrom-
etry (Figure 2B). According to their functions, the identified
proteins were divided into 8 functional clusters: I, membrane
protein, band 3; II, cytoskeleton network proteins -spectrin and
-actin; III, ankyrin complex proteins, ankyrin, band 4.2; IV,
membrane junctional complex proteins, band 4.1, p55, -adducin;
V, intracellular signaling protein; VI, metabolic enzymes, such as
GAPDH; VII, stress response proteins, such as catalase; and VIII
cell trafficking protein, such as Ras-related proteins (Table 2).
Of note, we found a Tyr-phosphorylated -spectrin fragment in
both F1 and F2 fractions from ChAc patients, and we identified a
phosphopeptide of -adducin (R.MLDNLGYR.T) in the dense
RBC fraction from ChAc subjects (Table 2). These results
Figure 2. Tyr phosphorylation of RBC membrane protein is increased in ChAc compared with normal controls. RBCs from control (C) and ChAc subjects were
fractionated as described in “Study design” and in the legend of Figure 1B-E. Western blot (Wb) analysis with specific anti–phosphotyrosine (PY) antibodies of RBC membrane
proteins separated by either bidimensional electrophoresis (2DE) or monodimensional electrophoresis (1DE). (A) Twin 2DE gels were run: one used for colloidal
Coomassie-stained gels (Figure 1D) and the other for the Western blot analysis with specific anti–phosphotyrosine (PY) antibodies. Top panel: Membranes of high-density
RBC fraction (F2) from control (C) and ChAc subjects. Similar results were also obtained in low-density RBC fraction (F1) from control and ChAc (data not shown). Bottom
panel: Dephosphorylation of blotted proteins by recombinant  protein phosphatase (400 U/mL). The blotted membranes were incubated in TBS containing 1% BSA, 0.1%
Triton X-100, 2mM MnCl2 (overnight at 4°C), and then probed with anti–phosphotyrosine antibodies. The data are representative for 3 experiments with similar results. (B) 1DE
gels (13 cm) were blotted for Western blot (Wb) analysis with specific anti–phosphotyrosine (PY) antibodies. The bands with different staining intensities were identified by
mass spectrometry (Table 2; “Comparative proteomic analysis”; supplemental Methods). Actin was used as a loading control. The data are representative of 8 experiments.
See also supplemental Figure 1B for densitometric analysis of the Tyr phosphorylation profile of the RBC membrane proteins.
Table 2. Proteins with different degrees of Tyr phosphorylation in RBC membranes from control and ChAc subjects
Band
no. AC Protein Theoretical protein MW, kDa Matching peptide Coverage, %
1 P11277 -spectrin (SPTB1) 246.468 146 50
2 P16157 Ankyrin (ANK1) 206.265 20 22
3 Q8WX82 -I Spectrin form  I  3 (fragment; Q8WX82) 117.549 14 20
4 P02730 Band 3 anion transport protein (B3AT) 101.792 16 18
5 P02730 Band 3 anion transport protein (B3AT) 101.792 23 24
6 Q9H4B4 Serine threonine protein kinase PLK3 ( PLK3) 71.629 6 8
7 P35612 -adducin (ADDB) 80.854 9 11
8 P11171 Band 4.1 (EPB41) 97.017 10 24
9 P16452 Band 4.2 (EPB42) 77.009 9 12
10 Q9H4B4 Serine threonine protein kinase PLK3 ( PLK3) 71.629 6 11
11 Q00013 55-kDa erythrocyte membrane protein (EM55) 52.296 19 34
12 Q00013 55-kDa erythrocyte membrane protein (EM55) 52.296 6 18
13 P47895 Aldehyde dehydrogenase family 1 member A3 (AL1A3) 56.108 3 6
14 P04040 Catalase (CATA) 59.756 4 9
15 O94921 Serine threonine protein kinase PFTAIRE-1 (CDK14) 53.057 5 10
16 Q14012 Calcium calmodulin-dependent protein kinase type 1 (KCC1A) 41.337 4 10
17 P60709 -actin (ACTB) 41.737 10 34
18 Q96GD4 Serine threonine protein kinase 12 (AURKB) 39.311 4 15
19 P04406 Glyceraldehyde-3-P-dehydrogenase (G3P) 36.053 9 36
20 P27105 Stomatin (STOM) 31.731 10 40
21 P00918 Carbonic anhydrase 2 (CAH2) 29.246 3 11
22 Q96E17 Ras-related protein Rab-3C (RAB3C) 25.952 3 17
The corresponding bands are indicated in Figure 2B. The success rate of protein identification by matrix-assisted laser desorption/ionization time-of-flight mass
spectrometry/mass spectrometry was 82% 
 6.7% (n  9).
AC indicates accession number; and MW, molecular weight.
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suggest that altered phosphorylation may contribute to acantho-
cytosis in ChAc.
Lyn is abnormally activated in ChAc RBCs and is independent
from Syk sequential phosphorylation
Because Tyr-kinase Syk and the Src family kinase Lyn have been
described as being involved in modulating band 3 function in
healthy RBCs,27 we studied membrane association of Syk and Lyn
in control and ChAc erythrocytes.
In both F1 and F2 RBCs from ChAc patients, we observed an
increased membrane association of active Lyn (phospho-Lyn,
Figure 3A). In contrast, the amount of membrane-bound total and
active Syk (phospho-Syk) was almost undetectable in ChAc and
barely detectable in control RBCs (Figure 3A). We previously
reported a sequential phosphorylation of band 3 catalyzed by the
concerted action of Syk and Lyn, with Tyr-8 and Tyr-21 being first
targeted by Syk and thereby serving as docking sites for the Src
homology domain 2 (SH2) of Lyn. Lyn, once recruited, phosphory-
lates Tyr-359 and Tyr-904 of band 327 as well as other proteins,
such as spectrins and adducin (unpublished data).
We used specific antibodies against Tyr-8 on the N-terminal of
band 3, as a Syk target, and Tyr-904 on the transmembrane domain
of band 3, as a Lyn target. We found increased Tyr phosphorylation
at Tyr-904 compared with normal RBCs (Figure 3B). Phosphoryla-
tion of residue Tyr-8 was almost absent in both fractions from
ChAc RBCs and only slightly detectable in normal RBCs. Since we
have previously reported that activated Syk might be present in the
cytoplasm in a truncated form,21 we evaluated Syk activity in the
cytoplasm. Syk activity was similar in the cytoplasm of normal and
ChAc RBCs (data not shown), suggesting a peculiar membrane
recruitment of Lyn to ChAc membranes that occurs independent of
preceding phosphorylation of band 3 by Syk.
To evaluate whether the Tyr-phospho profile of ChAc RBC
membrane might be affected by in vitro Lyn inhibition, we
incubated control and ChAc RBCs with both PP1 and PP2, Src
family kinase inhibitors, to obtain a more stable inhibition of
kinase activity. As shown in Figure 3C, in ChAc RBCs the
PP1/PP2 treatment markedly reduced Tyr-phosphorylation state
of several bands, including band 3, thus supporting the role of
Src kinase as determinant of the peculiar ChAc RBC membrane
Tyr-phosphorylation profile.
Because the amount of Lyn was markedly higher in ChAc erythro-
cytes than in control RBCs, we characterized Lyn RBC membrane
association. Lyn was almost entirely solubilized by the treatment with
Triton-X 100 in both control and ChAc RBCs (Figure 4A lanes 2 and
3 and lanes 7 and 8). However, treatment with high ionic strength
medium (0.6M NaCl, see “Study design”) resulted in remarkably
increased extraction of Lyn from ChAc RBC membranes compared
with that from membranes of control cells, accounting for the increased
Lyn concentration (Figure 4A lanes 4 and 5 vs lanes 9 and 10). These
data suggest there are several pools of Lyn in ChAc RBCs, which
associate with the membrane by multiple modes. This is corroborated by
the observation that a fraction of Lyn was released from ChAc RBC
membranes by agents capable of disrupting the SH2 domain/phospho-
Tyr interaction, such as GST-Lyn/SH2 and the phosphorylated NH2
terminus of band 3 (Figure 4B).
Figure 3. ChAc RBCs show increased Lyn Tyr kinase
associated with the membrane. RBCs from control (C)
and ChAc were fractionated as described in “Study
design” and in the legend of Figure 1B-E. (A) Western
blot analysis with specific antibodies of membrane-
associated Tyr kinase Lyn and phospho-Lyn (p-Lyn),
Syk, and phospho-Syk (p-Syk). Actin was used as a
loading control. Shown is a representative of 6 experi-
ments. Vertical line(s) have been inserted to indicate a
repositioned gel lane. (B) Western blot (Wb) analysis
with specific antibodies against Tyr-8 on the N-terminal
of band 3, as a Syk target, and Tyr-904 on the
transmembrane domain of band 3 (as a Lyn target). We
used normal RBCs treated with Na-vanadate (see
“Study design”) as positive controls. Total band 3 was
used as loading control. (C) Western blot (Wb) analysis
with specific anti–phosphotyrosine (PY) antibodies of
high-density fraction (F2) of RBCs from control (C) and
ChAc subjects are shown. The F2 RBCs were incu-
bated with or without the Src family kinase inhibitors
PP1 (10	M) and PP2 (10	M) as previously reported.19
The arrows indicated the bands affected by PP1-PP2
treatment in ChAc RBCs compared with untreated
ChAc RBCs. The data are representative of 3 experi-
ments (on 6-cm gels). Actin was used as a loading
control. The data are representative of 3 experiments.
Similar results were also obtained with cells from low
density fraction (F1) control and ChAc RBCs (data not
shown).
Syk-INDEPENDENT Lyn ACTIVATION 5657BLOOD, 17 NOVEMBER 2011  VOLUME 118, NUMBER 20
Exogenous Lyn phosphorylates several targets in ChAC RBC
membrane independent of Syk
We then evaluated whether in ChAc RBCs the ability of Lyn to
phosphorylate RBC membrane proteins in vitro was still dependent
on a Syk-related mechanism. Preparations from control and ChAc
RBC membranes were washed free of the phosphatase inhibitor
vanadate and resealed with exogenous Lyn in the presence and
absence of GST-Lyn/SH2 and GST-Lyn/SH3 domains. Exogenous
Lyn was shown to phosphorylate ChAc membrane proteins much
more efficiently than control fractions (Figure 5). In addition, the
Tyr phosphorylation profile remained unaltered in the presence of
the GST-Lyn/SH3 domain, with only a slight decrease when the
GST-Lyn/SH2 domain was added (Figure 5). These data indicate
that the ability of Lyn to Tyr-phosphorylate ChAc membrane
proteins is not dependent on a preceding membrane binding and
activity of Syk as previously reported for control RBCs.27 Thus,
ChAc-associated alterations in the membrane protein organization
may allow Lyn to target its substrates independently from Syk.
Interestingly, exogenous Lyn promotes Tyr phosphorylation of
membrane proteins other than band 3, similarly to that observed in
the naturally occurring Tyr phosphorylation profile of ChAc RBC
membranes (Figures 3A and 5). It is of note that in vitro
phosphorylation of ChAc RBC membrane by exogenous Lyn
involved a smaller number of proteins (bands) at molecular weights
lower than 48 kDa compared with intact ChAc RBCs. Otherwise,
these proteins showed reduced Tyr phosphorylation in PP1/PP2-
treated ChAc RBCs, suggesting that Lyn might be also part of other
signaling pathways involving other kinases or play a role as
downstream regulator of phosphatase(s) similarly to what we
previously described in other RBC models.31,32
Bioinformatic analysis of the differentially Tyr-phosphorylated
proteins reveals Lyn targets in ChAc RBCs
To evaluate the presence of possible Lyn targets on ChAc RBC
membrane proteins differentially Tyr-phosphorylated, we carried
out an extensive bioinformatic analysis of putative Lyn target sites
in the Tyr-phosphorylated proteins identified. This analysis reveals
that approximately 75% of the proteins have at least one highly
Lyn-selective site (Table 3). Only 3 of them (aldehyde dehydroge-
nase, carbonic anhydrase, and glyceraldehyde dehydrogenase)
show low specificity and 2 (stomatin and rab) an even lower
specificity for Lyn, with increased specificity for other Src kinase
members (data not shown). Because we found a highly phosphory-
lated -spectrin peptide in the proteomic analysis and also identi-
fied a -adducin phosphopeptide, we carried out a sequence
structure analysis of -spectrin or -adducin to further characterize
the Lyn targets in these 2 proteins. The analysis of the sequence of
-spectrin for Lyn-directed peptides with a high threshold score
more than 2.4 identified 5 peptides (Table 3). An intercrossed
search to identify whether these peptides could also serve as
substrates for Src Tyr kinases restricted the Lyn-specific target
Figure 4. Modes of interaction of Lyn with membranes from ChAc RBCs. (A) Membranes of F2 RBCs from control (C) and ChAc subjects were extracted with Triton X-100
or NaCl (see “RBC morphology, membrane preparation, and membrane cytoskeleton extraction”) and assayed after ultracentrifugation for the presence of Lyn by Western blot
(Wb) analysis. The data shown here are obtained with F2 ChAc RBCs. Similar data were obtained with F1 control and ChAc RBCs (data not shown). (B) Membranes of F2
RBCs from control (C) and ChAc subjects were incubated in the presence or absence of GST-Lyn/SH3, GST-Lyn/SH2, cdb3, or phospho (p)–cdb3 and assayed after
ultracentrifugation for Lyn in the resulting soluble (S) and pellet (P) fractions for the presence of Lyn by Western blot (Wb) analysis. Similar data were obtained from F1 control
and ChAc RBCs (data not shown). The membranes were reprobed with anti–actin antibody as loading control.
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sequences to 2 Tyr residues Tyr-307 and Tyr-1590. Inspection of
the 3D structure indicated that the Tyr-307 is located inside the
triple-helical bundle, whereas Tyr-1590 is in the linker region
preceding repeat 14, at the interface of the ankyrin binding domain
(repeats 14 and 15)33-35 (Table 3). The phosphopeptide of -addu-
cin (Tyr-377) is a specific target of Lyn with little specificity for Src
(Table 3) and is located in a highly conserved sequence of the neck
domain of the protein.36
Lyn-mediated phosphorylation of ChAc membranes alters the
interaction of band 3 with -adducin
We then evaluated the role of Lyn-dependent phosphorylation of
band 3 in the interaction with -adducin in ChAc RBCs compared
with normal erythrocytes. We first phosphorylated band 3 by
exogenous Syk with or without exogenous Lyn using normal RBC
membranes and then extracted by Triton-X (Figure 6A). The
immunoprecipitated band 3 from the resulting extract was further
subjected to immunoblot analysis with anti–adducin antibody. As
shown in Figure 6B, in control erythrocytes the presence of
-adducin in the band 3 immunoprecipitate was dramatically
decreased only if the membranes were sequentially phosphorylated
by Syk and Lyn. Because in ChAc RBCs we have shown band
3 Tyr-phosphorylated by Lyn independently from Syk phosphoryla-
tion, we immunoprecipitated band 3 from ChAc extracts, and we
observed a small amount of -adducin coimmunoprecipitated. This
increased further when membranes were incubated in the presence
of the Src kinase inhibitor PP2, suggesting that the altered Lyn
activity was implicated in the mechanism of association between
band 3 and -adducin in ChAc RBCs.
Discussion
An integrated proteomic approach enabled us to analyze the
perturbation of membrane protein organization in ChAc RBCs at
the molecular level. Our analysis indicated that this membrane
perturbation mainly affects the multiprotein complexes that anchor
the cytoskeleton to the membrane through band 3. The ChAc-
related alterations in the membrane association of GAPDH and
hemoglobin also suggest a perturbation of their binding sites on
band 3. These observations are in agreement with the reduction in
association of Prx-2 with the membrane, which may be the result of
unavailability of the Prx-2 docking site on band 3, as has also been
reported in -thalassemic RBCs.22 These data confirm and extend
previous observations of neuroacanthocytosis-associated altera-
tions on band 310 and extend these to ChAc-specific alterations in
band 3 function.
Previous studies have shown that the Tyr phosphorylation state
of RBC membrane proteins is involved in regulation of membrane
cohesion and mechanical stability.29 Accordingly, we found that
several membrane proteins are highly Tyr-phosphorylated in ChAc
RBCs compared with controls. These proteins are band 3 and other
components of the 2 anchoring complexes. Because band 3 is part
of both complexes, these findings suggest that phosphorylation-
induced perturbation of protein-protein interactions may be cen-
tered on band 3. Changes in the protein phosphorylation state can
modify protein-protein interactions and thereby multiprotein com-
plex formation and/or functions.37,38
Previous studies documented that the Syk-Lyn signaling path-
way working in concert can modify band 3 function in healthy
RBCs.27 It is noteworthy that we found increased association of
active Lyn with the ChAc membranes in the absence of Syk. This is
surprising because Syk is responsible for the primary Tyr phosphor-
ylation of band 3 that precedes membrane recruitment of Lyn in
normal RBCs.27 In ChAc membranes, the membrane-associated
form of Lyn was normally solubilized by detergent but differen-
tially partitioned by ionic strength extraction. These data point
toward a contribution of electrostatic interactions in Lyn binding
and suggest the existence of different pools of Lyn associated with
the membrane. A small amount of Lyn was displaced from the
Figure 5. Phosphorylation patterns of normal and
ChAc RBC membranes by exogenous Lyn. Mem-
branes of high-density fraction (F2) of RBCs from control
(C) and ChAc subjects were incubated without (lanes 1
and 5) or with exogenous Lyn (lanes 2-4 and 6-8) and
with GST-Lyn/SH3 (lanes 3 and 7) or GST-Lyn/SH2
(lanes 4 and 8), respectively. Samples were then ana-
lyzed by Western blot (Wb) analysis with anti–phosphoty-
rosine antibodies. Similar data were obtained with F1
control and ChAc RBCs (data not shown). The mem-
branes were reprobed with anti–actin antibody as loading
control.
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ChAc membrane by the addition of GST-Lyn/SH2 or the phosphor-
ylated cytoplasmic domain of band 3. This suggests the unmasking
of the Lyn domain on band 3, which allows Lyn to bind
independently from the action of Syk. The conspicuous increase in
Tyr phosphorylation state of ChAc RBC membrane proteins by
exogenous Lyn supports this hypothesis.
Bioinformatic analyses show that in large part the differentially
Tyr-phosphorylated proteins identified in ChAc indeed contain
Table 3. Bioinformatic analysis of the differently Tyr-phosphorylated proteins identified in ChAc RBCs
Band no. AC Protein Lyn-target Score
1 P11277 -spectrin (SPTB1) Y-307* 2.447
Y-474 3.596
Y-493 3.383
Y-660 4.128
Y-1590* 3
2 P16157 Ankyrin (ANK1) Y-884 3.83
Y-1468 2.362
Y-1750 2.447
3 Q8WX82 -I spectrin form  I  3 (fragment) (Q8WX82) Y-307* 2.447
Y-474 3.596
Y-493 3.383
Y-660 4.128
Y-1590* 3
4 P027330 Band 3 anion transport protein (B3AT) Y-8 8.809
Y-21 6.553
Y-46 4.149
Y-359 4.702
Y-904 5.915
5 P027330 Band 3 anion transport protein (B3AT) Y-8 8.809
Y-21 6.553
Y-46 4.149
Y-359 4.702
Y-904 5.915
6 Q9H4B4 Serine threonine protein kinase PLK3 ( PLK3) Y-136 2.383
7 P35612 -adducin (ADDB) Y-377* 0.66
8 P11171 Band 4.1 (EPB41) Y-374 2.489
9 P16452 Band 4.2 (EPB42) Y-435 2.085
10 Q9H4B4 Serine threonine protein kinase PLK3 ( PLK3) Y-136 2.383
11 Q00013 55-kDa erythrocyte membrane protein (EM55) Y-331 2.468
Y-429 2.83
12 Q00013 55-kDa erythrocyte membrane protein (EM55) Y-331 2.468
Y-429 2.83
13 P47895 Aldehyde dehydrogenase family 1 member A3 (AL1A3) Y-497 1.683†
14 P04040 Catalase (CATA) Y-260 1.809
15 O94921 Serine threonine protein kinase PFTAIRE-1 (CDK14 Y-135 4.17
16 Q14012 Calcium calmodulin-dependent protein kinase type 1 ( KCC1A) Y-20 2.872
Y-235 2.723
17 P60709 -actin (ACTB) Y-240 2.702
18 Q96GD4 Serine threonine protein kinase 12 (AURKB) Y-8 2.319
19 P04406 Glyceraldehyde-3-P-dehydrogenase (G3P) Y-255 1.66†
20 P27105 Stomatin (STOM) Y-60 0.213‡
Y-123 0.404‡
Y-124 0.234‡
Y-252 0.426‡
21 P00918 Carbonic anhydrase 2 (CAH2) Y-40 1.511†
Y-51 1.745†
Y-114 1.681†
22 Q96E17 Ras related protein Rab-3C (RAB3C) Y-17 0.809‡
Y-29 0.383‡
Y-50 0.298‡
Y-92 0.638‡
Y-99 0.596‡
Y-100 0.638‡
Y-110 0.191‡
Y-131 0.234‡
*Identified phosphopeptides of -spectrin and -adducin.
†Low threshold analysis.
‡Very low threshold analysis.
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Lyn-specific targets or putative Src kinase family substrates. In
addition, the sequence-structure study allowed us to propose
specific Lyn phosphorylation sites on -adducin and -spectrin,
supporting the multitarget action of abnormally activated Lyn in
ChAc RBCs. Notably, Tyr-377 of -adducin, which is phosphory-
lated in ChAc RBCs, is highly conserved.36 This residue is located
in the neck region that is involved in association of adducin
monomers to heterodimers, thereby constituting the functionally
active form of the protein. This conserved sequence in the neck
region of adducin is also involved in the organization of an
amphiphilic structure, which is important in mediating protein-
protein interactions.39 In ChAc RBCs, -adducin was coimmuno-
precipitated with band 3 only in the presence of the Src kinase
inhibitor PP2, whereas in control erythrocytes there was a require-
ment for sequential Syk-Lyn band 3 phosphorylation. Thus,
changes in the Tyr phosphorylation state of -adducin in this region
probably affect its interactions with the other proteins of the
junctional complexes and thereby the stability of the RBC mem-
brane protein bridges.
Our data suggest a novel mechanism in generation of acantho-
cytes in ChAc in addition to those reported in McLeod syndrome, a
neuroacanthocytosis-related disorder, and in abetalipoproteinemia.
In these diseases, acanthocytes formation has been related to either
the absence of the XK membrane protein convalently linked to the
Kell glycoprotein and part of the multiprotein 4.1 juctional
complex as in McLeod syndrome or to the abnormal membrane
lipid composition (increased sphingomielin/lecithin ratio) with
abnormalities of lipid-lipid interaction within membrane as in
abetaliproteinemia.40,41 In ChAc RBCs, there is no indication of
abnormalities in either membrane lipid composition or membrane
and cytoskeletal protein content. We did, however, find alterations
in Tyr-phosphorylation state of membrane proteins and in the
signal transduction pathway. Thus, we propose that in ChAc RBCs
the “Lyn storm” might affect the organization of the complexes
bridging the membrane to the cytoskeleton, most likely by inducing
abnormal protein interactions through the opening of SH2 binding
sites in a Syk-independent manner. This might result in the
heterogeneous distribution of the cytoskeleton as observed in
electron microscopy studies,8 and may be similar to the concentra-
tion of Lyn in plasma membrane patches of activated platelets,
adjacent to granules.42,43 In addition, abnormal Lyn phosphoryla-
tion might also contribute to altered vesiculation of ChAc RBCs.
Lyn has been found in association with the exosomes that are
excreted by reticulocytes, containing lipid raft domains, and in
vesicles from mature RBCs.44-46 Together with the indication for a
stomatin-specific, raft-based process in vesicle formation in vitro,47
this supports the hypothesis that vesicle formation is an important,
active process in the formation of acanthocytes. This is in
agreement with increased concentrations in ChAc RBC membranes
of various small G-proteins involved in vesicle formation and
transport.10
In conclusion, our data link, for the first time, the presence of
abnormal RBCs in patients with ChAC with evidence for an
independent and strong Lyn activation. The ChAc-associated
alterations in RBC membrane-protein organization appear to be the
result of increased Tyr phosphorylation leading to altered linkage
Figure 6. Effect of phosphorylation of RBC membranes by Syk and/or Lyn on band 3 binding to -adducin in normal and ChAc RBC membranes. (A) Membranes
(lanes 1 and 2) or Syk-phospho-membranes (lanes 3 and 4) of F2 RBCs from control (C) were incubated without (lanes 1 and 3) or with exogenous Lyn (lanes 2 and 4) and
subjected to Western blot analysis with anti–phospho-Tyr (anti–pTyr) antibody (top panel) or were extracted with Triton X-100 and assayed after ultracentrifugation for
the presence of band 3 by Western blot analysis (bottom panel). The membranes were reprobed with anti–actin antibody as loading control. (B) Band 3 was
immunoprecipitated from membranes (lanes 1 and 2) and Syk-phospho-membranes (lanes 3 and 4) of F2 RBCs from C after incubation without (lanes 1 and 3) or with
exogenous Lyn (lanes 2 and 4). The immunoprecipitates were subjected to Western blot analysis with anti–pTyr (top panel), anti–-adducin antibody. The blots were
also probed with anti–band 3 antibody. (C) Band 3 was immunoprecipitated from membranes of F2 ChAc RBCs previously incubated without or with the inhibitor PP2
(10	M). The immunoprecipitates were subjected to Western blot analysis with anti–-adducin antibody. The blots were also probed with anti–band 3 antibody.
The figure is representative of 3 independent experiments.
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of band 3 to the junctional complexes involved in anchoring the
membrane to the cytoskeleton. The latter may promote an in-
creased degree of freedom of the junctional complexes bridging the
membrane to the cytoskeleton and affect the association of the
cytoskeleton with the plasma membrane. The present data open
new ways to explore the pathobiology of acanthocytes and
pathophysiologic mechanisms of neurodegeneration in patients
with neuroacanthocytosis.
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